Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Cupric chloride treatment corrected abnormal Purkinje cell development in brindled mice.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

The keratin 5 mutation in a family with epidermolysis bullosa simplex was due to mosaicism, not a new mutation.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Early skin biopsy is crucial for diagnosing Conradi-Hünermann-Happle syndrome.

Belimumab may cause hair loss in lupus patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Defective protein folding due to a mutation is key in ANE syndrome.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The condition might be caused by genetic changes after birth.